https://www.businessinsider.com/long-term-coronavirus-immunity-t-cells-2020-8?amp
Some early studies have suggested that coronavirus antibodies fade relatively quickly, but that doesn't mean immunity vanishes.
A new study found that all participants infected with COVID-19 — even those with asymptomatic or mild cases and patients who didn't have detectable antibodies — developed virus-specific T cells.
T cells identify and kill infected cells, and B cells create new antibodies. Those cells can attack the virus if it ever returns.
So the new finding is strong evidence that all patients likely develop long-term immunity.
"Memory T cells will likely prove critical for long-term immune protection against COVID-19," the study authors wrote, adding that they "may prevent recurrent episodes of severe COVID-19."
That's because memory T cells can stick around for years, while antibody levels drop following an infection.
Even patients without antibodies have virus-specific T cells
The authors of the new study examined blood from 206 people in Sweden who had COVID-19 with varying degrees of severity. They found that regardless of whether a person had recovered from a mild or severe case, they still developed a robust T-cell response. Even coronavirus patients who did not test positive for antibodies developed memory T cells, the results showed.
PS: The Study, published on Cell
https://www.cell.com/cell/fulltext/S0092-8674(20)31008-4?rss=yes
Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19
Highlights
- 1.
Acute phase SARS-CoV-2-specific T cells display an activated cytotoxic phenotype
- 2.
Broad and polyfunctional SARS-CoV-2-specific T cell responses in convalescent phase
- 3.
Detection of SARS-CoV-2-specific T cell responses also in seronegative individuals